{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:26:38Z","timestamp":1791206798470,"version":"4.1.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2013,2,20]],"date-time":"2013-02-20T00:00:00Z","timestamp":1361318400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0056521","type":"journal-article","created":{"date-parts":[[2013,2,20]],"date-time":"2013-02-20T23:30:08Z","timestamp":1361403008000},"page":"e56521","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Multiple Consequences of a Single Amino Acid Pathogenic RTK Mutation: The A391E Mutation in FGFR3"],"prefix":"10.1371","volume":"8","author":[{"given":"Fenghao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarvenaz","family":"Sarabipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalina","family":"Hristova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,2,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ng1295-462","article-title":"Fibroblast-Growth-Factor-Receptor-3 (Fgfr3) Transmembrane Mutation in Crouzon-Syndrome with Acanthosis Nigricans","volume":"11","author":"GA Meyers","year":"1995","journal-title":"Nat Genet"},{"key":"ref2","first-page":"23","article-title":"The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: The achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans","volume":"21","author":"Z Vajo","year":"2000","journal-title":"Endocrine Reviews"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0005-2736(70)90001-5","article-title":"The isolation and characterization of the plasma membrane from chick embryo fibroblasts","volume":"196","author":"JF Perdue","year":"1970","journal-title":"Biochim Biophys Acta"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1098-1004(1999)14:2<115::AID-HUMU3>3.0.CO;2-2","article-title":"Clinical spectrum of fibroblast growth factor receptor mutations","volume":"14","author":"MR Passos-Bueno","year":"1999","journal-title":"Human Mutation"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cytogfr.2005.01.001","article-title":"Cellular signaling by fibroblast growth factor receptors","volume":"16","author":"VP Eswarakumar","year":"2005","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1073\/pnas.0307287101","article-title":"Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity","volume":"101","author":"SK Olsen","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1247\/csf.25.85","article-title":"The pleiotropic effects of fibroblast growth factor receptors in mammalian development","volume":"25","author":"I Mcintosh","year":"2000","journal-title":"Cell Structure and Function"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00774-008-0009-7","article-title":"FGFR3-related dwarfism and cell signaling","volume":"27","author":"D Harada","year":"2009","journal-title":"Journal of Bone and Mineral Metabolism"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.yexcr.2004.11.012","article-title":"Cell responses to FGFR3 signaling: growth, differentiation and apoptosis","volume":"304","author":"CGM L'Horte","year":"2005","journal-title":"Experim Cell Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ng0496-390","article-title":"Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3","volume":"12","author":"JS Colvin","year":"1996","journal-title":"Nat Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(07)61090-3","article-title":"Achondroplasia","volume":"370","author":"WA Horton","year":"2007","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jmb.2005.11.077","article-title":"FGFR3 dimer stabilization due to a single amino acid pathogenic mutation","volume":"356","author":"E Li","year":"2006","journal-title":"J Mol Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.bbamem.2011.04.007","article-title":"The A391E mutation enhances FGFR3 activation in the absence of ligand","volume":"1808","author":"F Chen","year":"2011","journal-title":"Biochimica et Biophysica Acta-Biomembranes"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/MCB.12.1.240","article-title":"Heparin Is Required for Cell-Free Binding of Basic Fibroblast Growth-Factor to A Soluble Receptor and for Mitogenesis in Whole Cells","volume":"12","author":"DM Ornitz","year":"1992","journal-title":"Mol Cell Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1042\/BST0340442","article-title":"Insights into the role of heparan sulphate in fibroblast growth factor signalling","volume":"34","author":"NJ Harmer","year":"2006","journal-title":"Biochemical Society Transactions"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0092-8674(00)80051-3","article-title":"Structural basis for FGF receptor dimerization and activation","volume":"98","author":"AN Plotnikov","year":"1999","journal-title":"Cell"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"30103","DOI":"10.1074\/jbc.M109.094086","article-title":"The physical basis behind achondroplasia, the most common form of human dwarfism","volume":"285","author":"L He","year":"2010","journal-title":"J Biol Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jmb.2008.10.036","article-title":"Pathogenic activation of receptor tyrosine kinases in mammalian membranes","volume":"384","author":"L He","year":"2008","journal-title":"J Mol Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M","article-title":"FGFs, heparan sulfate and FGFRs: complex interactions essential for development","volume":"22","author":"DM Ornitz","year":"2000","journal-title":"BioEssays"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"8576","DOI":"10.1021\/bi200986f","article-title":"The Physical Basis of FGFR3 Response to fgf1 and fgf2","volume":"50","author":"FH Chen","year":"2011","journal-title":"Biochemistry"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"13272","DOI":"10.1074\/jbc.M110.205583","article-title":"FGFR3 heterodimerization in achondroplasia, the most common form of human dwarfism","volume":"286","author":"L He","year":"2011","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.molcel.2006.01.022","article-title":"Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction","volume":"21","author":"CM Furdui","year":"2006","journal-title":"Molecular Cell"},{"key":"ref23","first-page":"ra6","article-title":"The precise sequence of FGF receptor autophosphorylation is kinetically driven and is disrupted by oncogenic mutations","volume":"2","author":"ED Lew","year":"2009","journal-title":"Science Signaling"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbamem.2010.08.007","article-title":"Specific inhibition of a pathogenic receptor tyrosine kinase by its transmembrane domain","volume":"1808","author":"LJ He","year":"2011","journal-title":"Biochimica et Biophysica Acta-Biomembranes"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1096\/fasebj.3.1.2783412","article-title":"High-Yield Trapping of Egf-Induced Receptor Dimers by Chemical Cross-Linking","volume":"3","author":"BO Fanger","year":"1989","journal-title":"FASEB J"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1128\/MCB.20.2.516-522.2000","article-title":"The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation","volume":"20","author":"E Monsonego-Ornan","year":"2000","journal-title":"Mol Cell Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/339230a0","article-title":"A Point Mutation in the Neu Oncogene Mimics Ligand Induction of Receptor Aggregation","volume":"339","author":"DB Weiner","year":"1989","journal-title":"Nature"},{"key":"ref28","first-page":"3684","article-title":"Detection of beta(2)-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET)","volume":"97","author":"S Angers","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0168-9525(00)02021-7","article-title":"RTK mutations and human syndromes - when good receptors turn bad","volume":"16","author":"SC Robertson","year":"2000","journal-title":"Trends Genet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/316892","article-title":"Distinct missense mutations of the FCFR3 Lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype","volume":"67","author":"GA Bellus","year":"2000","journal-title":"American Journal of Human Genetics"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng0696-233","article-title":"Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia","volume":"13","author":"MC Naski","year":"1996","journal-title":"Nat Genet"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1021\/bi060609y","article-title":"Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies","volume":"45","author":"E Li","year":"2006","journal-title":"Biochemistry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4161\/cam.4.2.10725","article-title":"Receptor Tyrosine Kinase transmembrane domains: function, dimer structure, and dimerization energetics","volume":"4","author":"E Li","year":"2010","journal-title":"Cell Adhesion and Migration"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/j.1460-2075.1996.tb00384.x","article-title":"Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia","volume":"15","author":"MK Webster","year":"1996","journal-title":"EMBO J"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.bbamem.2011.07.044","article-title":"Physical-chemical principles underlying RTK activation, and their implications for human disease","volume":"1818","author":"L He","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.2002.17.5.860","article-title":"Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization","volume":"17","author":"R Adar","year":"2002","journal-title":"J Bone Miner Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cytogfr.2005.01.008","article-title":"Structural basis for fibroblast growth factor receptor activation","volume":"16","author":"M Mohammadi","year":"2005","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/hmg\/ddh235","article-title":"Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities","volume":"13","author":"OA Ibrahimi","year":"2004","journal-title":"Human Molecular Genetics"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/hmg\/ddh011","article-title":"Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity","volume":"13","author":"OA Ibrahimi","year":"2004","journal-title":"Human Molecular Genetics"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/08977190600621388","article-title":"Reduced binding of FGF1 to mutant fibroblast growth factor receptor 3","volume":"24","author":"D Khnykin","year":"2006","journal-title":"Growth Factors"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/bies.20582","article-title":"Mutational activation of ErbB family receptor tyrosine kinases: insights into mechanisms of signal transduction and tumorigenesis","volume":"29","author":"DJ Riese","year":"2007","journal-title":"BioEssays"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ccr.2006.12.017","article-title":"Structures of lung cancer-derived EGFR mutants and inhibitor complexes: Mechanism of activation and insights into differential inhibitor sensitivity","volume":"11","author":"CH Yun","year":"2007","journal-title":"Cancer Cell"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1091\/mbc.11.10.3589","article-title":"Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase","volume":"11","author":"CA Bell","year":"2000","journal-title":"Mol Biol Cell"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1073\/pnas.2237184100","article-title":"Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia","volume":"101","author":"JY Cho","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1111\/j.1742-4658.2007.05835.x","article-title":"The localization of FGFR3 mutations causing thanatophoric dysplasia type I differentially affects phosphorylation, processing and ubiquitylation of the receptor","volume":"274","author":"J Bonaventure","year":"2007","journal-title":"Febs Journal"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0056521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T23:38:51Z","timestamp":1562715531000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0056521"}},"subtitle":[],"editor":[{"given":"Anna","family":"Tramontano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,2,20]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0056521","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,20]]}}}